Influenza A H1N1 Hemagglutinin Antibody (2F1A7) [Janelia Fluor® 635]

Product Discontinued

Influenza A H1N1 Hemagglutinin Antibody (2F1A7) [Janelia Fluor® 635] Summary

• Immunogen: This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Influenza A H1N1 (Accession#: ABD77675.1; Met 1-Gln 528).
• Specificity: No cross-reactivity in ELISA with:
  
  H1N1 (A/BrevigMission/1/1918) HA
  H1N1 (A/Brisbane/02/2018) HA
  H1N1 (A/Brisbane/59/2007) HA
  H1N1 (A/Brisbane/59/2007) HA1
  H1N1 (A/California/04/2009) HA
  H1N1 (A/California/04/2009) HA1
  H1N1 (A/California/07/2009) HA
  H1N1 (A/Guangdong-Maonan/SWL1536/2019) / (A/Hawaii/70/2019) HA
  H1N1 (A/Michigan/45/2015) HA
  H1N1 (A/New Caledonia/20/1999) HA
  H1N1 (A/Ohio/UR06-0091/2007) HA
  H1N1 (A/Solomon Islands/3/2006)
  H1N1 (A/Wisconsin/588/2019) / (A/Victoria/2570/2019) HA
  H1N1 (A/WSN/1933) HA
  H1N2 (A/swine/Guangxi/13/2006) HA
  H1N3 (A/duck/NZL/160/1976)
  H3N2 (A/Brisbane/10/2007) HA
  H3N2 (A/Cambodia/e0826360/2020) HA
  H3N2 (A/Hong Kong/2671/2019) HA
  H3N2 (A/Hong Kong/45/2019) HA
  H3N2 (A/Hong Kong/4801/2014) HA
  H3N2 (A/Kansas/14/2017) HA
  H3N2 (A/Singapore/INFIMH-16-0019/2016) HA
  H3N2 (A/Switzerland/9715293/2013) HA
  H5N1 (A/Anhui/1/2005) HA
  H5N1 (A/Anhui/1/2005) HA2
  Influenza B (B/Brisbane/60/2008) HA
  Influenza B (B/Colorado/06/2017) HA
  Influenza B (B/Florida/4/2006) HA
  Influenza B (B/PHUKET/3073/2013) HA
  Influenza B (B/Washington/02/2019) HA
• Isotype: IgG1
• Clonality: Monoclonal
• Host: Mouse
• Purity: Protein A purified

Applications/Dilutions

• Dilutions:
  • ELISA
  • Sandwich ELISA Detection
  • Western Blot
• Application Notes: Optimal dilution of this antibody should be experimentally determined.

Packaging, Storage & Formulations

• Storage: Store at 4C in the dark.
• Buffer: 50mM Sodium Borate
• Preservative: 0.05% Sodium Azide
• Purity: Protein A purified

Notes

Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.